By Aude Lecrubier

PARIS (Reuters Health) Apr 07 - A 12-week multicenter, double-blind study, presented at the 21st meeting of the European Urology Association, demonstrated that vardenafil (Levitra) for erectile dysfunction (ED) significantly improves rates of penetration and intercourse completion compared with placebo in PDE-5-naive men, and significantly improves partner satisfaction as well.

“I think that over the years, trials of erectile dysfunction have not attributed enough consideration to the couple component. Our new trial shows that successful therapy for erectile dysfunction with Levitra benefits both partners,” primary investigator Dr. David Edwards of White House Surgery, Chipping Norton, UK, said. Read the rest of this entry »

Susan Jeffrey

Results of a randomized trial show that use of tadalafil (Cialis, Eli Lilly) improved erectile function and was well tolerated by men with erectile dysfunction (ED) secondary to traumatic spinal cord injury (SCI).

Results of the trial were published online September 10 and scheduled for the November issue of the Archives of Neurology.

“As in other ED studies that included patients who were difficult to treat owing to preexisting conditions (eg, prostatectomy, diabetes mellitus), tadalafil was efficacious for the treatment of ED after a traumatic SCI,” the researchers, with first author Franc,ois Giuliano MD, PhD, from Raymond Poincare’ Hospital, in Garches, France, conclude. “On-demand treatment with tadalafil (10 mg or 20 mg) may help improve the sex lives of patients with ED and SCI and their partners.” Read the rest of this entry »

NEW YORK (Reuters Health) Nov 12 - Sildenafil(Viagra) acutely increases sperm motility in young infertile men, Italian researchers report in the October issue of Fertility and Sterility. The opposite is true for tadalafil(Cialis).

Dr. Giorgio Pomara and colleagues at the University of Pisa in Rome, administered a single 50 mg dose of sildenafil or 20 mg of tadalafil to 18 young infertile men in a randomized, double-blind crossover study with a two-week washout period between treatment arms. Read the rest of this entry »